Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | CASP7 | P55210 | 1/20 | 0.37 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22210737 | 0.84 | MEN1 (0.36) | MEN1GAAMAPTALOX15CASP1 | |
| SCHEMBL21186449 | 0.72 | MEN1 (0.43) | MEN1GAAMAPTALOX15KMT2A | |
| SCHEMBL19154083 | 0.65 | POLB (0.42) | GAA | |
| SCHEMBL22735008 | 0.63 | — | — | |
| SCHEMBL21974294 | 0.62 | GAA (0.32) | GAAMAPT | |
| SCHEMBL6422711 | 0.62 | MEN1 (0.36) | MEN1GAAMAPTALOX15CASP1 | |
| SCHEMBL21033784 | 0.62 | AKT1 (0.39) | MEN1MAPTALOX15KMT2A | |
| SCHEMBL25665552 | 0.59 | MAPT (0.31) | MAPTALOX15 | |
| SCHEMBL18714078 | 0.59 | — | — | |
| SCHEMBL23572391 | 0.58 | AKT1 (0.35) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10711091-B2 | Light-emitting device and method for producing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-07-14 | — | — | US | disclosed |
| US-20190048131-A1 | LIGHT-EMITTING DEVICE AND METHOD FOR PRODUCING SAME | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711091-B2 | Light-emitting device and method for producing same | SCO2, SUN2, SLC18A2 | MEN1 2564/4885GAA 2395/4885MAPT 386/4885 |
| US-20190048131-A1 | LIGHT-EMITTING DEVICE AND METHOD FOR PRODUCING SAME | SCO2, SUN2, SLC18A2 | MEN1 2564/4885GAA 2395/4885MAPT 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.